Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2015, Article ID 473430, 10 pages
http://dx.doi.org/10.1155/2015/473430
Review Article

The Molecular Mechanism Underlying Continuous Exercise Training-Induced Adaptive Changes of Lipolysis in White Adipose Cells

1Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, Mitaka, Tokyo 181-8611, Japan
2Graduate School of Health and Sports Science, Doshisha University, Kyotanabe, Kyoto 610-0394, Japan
3Faculty of Culture and Sport Policy, Toin University of Yokohama, Yokohama, Kanagawa 225-8503, Japan
4Department of Third Internal Medicine, Kyorin University, School of Medicine, Mitaka, Tokyo 181-8611, Japan

Received 6 February 2015; Revised 4 April 2015; Accepted 27 April 2015

Academic Editor: Eric Doucet

Copyright © 2015 Junetsu Ogasawara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Physical exercise accelerates the mobilization of free fatty acids from white adipocytes to provide fuel for energy. This happens in several tissues and helps to regulate a whole-body state of metabolism. Under these conditions, the hydrolysis of triacylglycerol (TG) that is found in white adipocytes is known to be augmented via the activation of these lipolytic events, which is referred to as the “lipolytic cascade.” Indeed, evidence has shown that the lipolytic responses in white adipocytes are upregulated by continuous exercise training (ET) through the adaptive changes in molecules that constitute the lipolytic cascade. During the past few decades, many lipolysis-related molecules have been identified. Of note, the discovery of a new lipase, known as adipose triglyceride lipase, has redefined the existing concepts of the hormone-sensitive lipase-dependent hydrolysis of TG in white adipocytes. This review outlines the alterations in the lipolytic molecules of white adipocytes that result from ET, which includes the molecular regulation of TG lipases through the lipolytic cascade.

1. Introduction

Obesity, which results from the energy intake that is in excess of energy expenditure, is a major global health problem not only in developed nations (western world) but in low- and middle-income countries (less developed countries) [1]. White adipocytes are capable of storing excess energy as triacylglycerol (TG), and they play a key role in energy metabolism by providing free fatty acids (FFA) and glycerol through the hydrolysis of TG. The induction of lipolysis, as well as the inhibition of TG synthesis in white adipocytes, has been considered a target of therapy for the prevention and improvement of obesity and its related disorders. Therefore, clarifying the mechanisms underlying the physical exercise-induced alteration of lipolytic molecules in white adipocytes would be useful for establishing a new method for exercise therapy as well as for understanding the biological meanings of the lipolytic events themselves.

This elucidation of lipolysis has demonstrated how ectopic lipid accumulation in skeletal muscle and liver is closely associated with insulin resistance syndrome and diabetes [2]. In particular, the flux of muscular fatty acids is known to play a pivotal role in the development of the abnormalities of muscle and whole-body energy metabolism [3], demonstrating that an increase in the consumption of intramuscular lipids via mitochondrial β-oxidation would be beneficial for the prevention of obesity-related disorders. Indeed, in previous studies, ET has been shown to increase the metabolic utilization of lipids in both healthy [4] and obese humans [5] and reduce lipid storage in liver [6]. In addition, it appears that ET-induced loss of the absolute content of lipid in white adipocytes per se has a positive effect on reducing the levels of the redistribution of lipids in other tissues through an attenuation of synthetic substrate content, that is, FFA and glycerol. Thus, ET would be a highly effective tool for reducing ectopic fat accumulation and/or increasing the hydrolysis of TG in white adipocytes themselves.

The molecular mechanisms underlying lipolysis in white adipocytes are known to be regulated mainly by hierarchical activation of the lipolytic cascade, which is modified through both an α- and β-AR-cAMP production system, thereby distally exerting a changeover to the hydrolytic action of lipases. The stimulation of these two ARs induces opposite effects: α-antilipolytic and β-lipolytic (details are described in the next section). Of note, it has been shown that complete activation of lipolysis in white adipocytes is only obtained when catecholamines were in the presence of an -AR antagonist in human, although there are no changes observed in rodents [7]. This -antilipolytic component counteracting the β-AR-mediated lipolysis has been well known as the “/β-adrenergic balance” [8]. On the other hand, Arner and colleagues [9] have shown that -ARs modulate lipolysis at rest, whereas the β-ARs modulate lipolysis during physical exercise, even if /β-adrenergic balance exists in human white adipocytes. In addition, it has been demonstrated that the number of -ARs in jerboa, dormouse, and rat is lower than that in humans [10], suggesting that catecholamines-induced lipolysis in rodents, which have low number of -ARs, is regulated through alteration in β-lipolytic function. Therefore, the experiments using the jerboa, dormouse, and rat would be helpful for elucidation of physical exercise-induced molecular changes in lipolytic molecules in human white adipocytes, because -ARs modulate lipolytic response during physical exercise in humans [9]. It has been widely accepted that ET facilitates hormone-stimulated lipolysis in white adipocytes in mammals [11, 12]. However, the effects of ET on both the molecular behavior and on the expression levels of lipolytic molecules in white adipocytes remain to be missing pieces of the puzzle, although recent evidence has identified both new lipase and lipolytic cofactors: adipose triglyceride lipase (ATGL) [13], PAT family proteins [14], comparative gene identification-58 (CGI-58) [15], and lipotransin [16].

The purpose of this review is to marshal the fact that exercise training (ET) induced changes in the lipolytic molecules via β-AR, commonly expressed in white adipocytes of human and rodents. The introduced results of this review are mixed with those obtained from human and experimental animals. However, the consideration of this viewpoint appears to enable a deepening of understanding lipolytic events in white fat cells by ET, because ET-induced adaptive changes of lipolytic molecules in white adipocytes are a universal mechanism in mammalian species. Together, first, the currently known mechanism(s) of the lipolytic cascade and the molecular behavior of lipases and cofactors are outlined. Then, attention is focused on the ET-induced adaptive changes of lipolytic molecules, which were mainly obtained from our studies of white adipocytes.

2. Basic Structure of the Lipolytic Cascade in White Adipocytes

Lipolysis in white adipocytes is regulated by a multifaceted phenomenon that is subject primarily to distinct temporal controls such as hormonal stimulation via catecholamines. The hormonal activation of lipolysis in adipocytes is mediated via a traditional cAMP-dependent signal transduction process [17, 18] (Figure 1(a)). The stimulation of G-protein coupled receptors (GPCRs), that is, -, -, and -adrenergic receptors (β-ARs), induces a conformational change in the Gα subunit of the heterotrimeric G protein (Gαβγ) that leads to GDP release and GTP binding. Activated Gαs leads to the activation of adenylyl cyclase (AC) and to the production of cAMP. However, the stimulation of GPCRs, that is, -adrenergic receptor [19], adenosine receptor [20], and prostaglandin E2 receptor [21], which stimulate Gαi, causes the inactivation of AC and reduces the production of cAMP, resulting in an attenuation of the lipolytic response. In addition, insulin attenuates intracellular cAMP production through increases in phosphodiesterase-3B (PDE-3B) activity, which changes cAMP to AMP via the activation of protein kinase B/AKT (Figure 1(b)). An increased intracellular cAMP level phosphorylates and activates cAMP-dependent protein kinase A (PKA) [22, 23] and subsequently phosphorylates hormone-sensitive lipase (HSL); it is well known that the phosphorylation of HSL at Ser563, Ser659, and Ser660, by cAMP-dependent protein kinase (PKA), enhances its enzymatic activity and that extracellular-regulated kinase (ERK) induces the phosphorylation of HSL at Ser600 in 3T3-L1 adipocytes [24], although there are no studies supporting this result in primary mammalian white adipocytes. Phosphorylated HSL activates the hydrolysis of TG in adipocytes [25] through the translocation of HSL from the cytoplasm to the surface of lipid droplets [26]. On the other hand, an inhibitory effect of insulin has been reported on HSL activity [27, 28], and AMP activated protein kinase (AMPK) attenuates HSL activity through an increase in its phosphorylation at Ser565 [29].

Figure 1: Lipolysis in white adipocytes is mainly regulated through GPCRs that localize on the plasma membrane. (a) Under stimulatory conditions, ligands binding to GPCRs, that is, -, -, and -AR, activate AC through the action of Gαs, resulting in an increase in PKA activity through the accumulation of intracellular cAMP, and, in turn, PKA phosphorylates and activates HSL. Phosphorylated HSL translocates on the lipid droplet and thereby activates lipolysis. (b) On the other hand, ligands binding to GPCRs, that is, -AR, adenosine-R, and nicotinic acid-R, attenuate lipolysis via a reduction in cAMP production. Insulin receptor signaling also inhibits lipolytic response via the activation of PDH-3B, a cAMP-degrading enzyme.

In 2004, three groups independently published the discovery of an enzyme that could hydrolyze TG [13, 30, 31] and named it adipose triglyceride lipase (ATGL). Unlike HSL, ATGL has no specificity for the hydrolysis of MG, cholesterol esters, or retinyl esters. ATGL does, however, have a substrate specificity for TG that is 10-fold higher than that for DG [3], indicating that it selectively acts as the first step in TG hydrolysis and that its hydrolytic function is not restricted to the catabolism of lipid droplets [32] in adipose tissue. Moreover, two phosphorylation sites of ATGL, at Ser404 and Ser428, have been identified in the C-terminal region in humans [13, 33]. In contrast with HSL, however, the functional roles of enzyme phosphorylation, as it involves protein kinases, remain unknown. Together, both HSL and ATGL act hierarchically to regulate TG hydrolysis: ATGL initiates lipolysis by removing the first FA from TG to, in turn, produce DG; HSL generates an additional FA from DG and MG to produce glycerol (Figure 2). In these events, the phosphorylation of lipases plays a central role in the regulation of enzyme activity and is closely associated with the catabolism of adipocytes.

Figure 2: ATGL acts exclusively on the hydrolysis of TG. A major component of HSL activity depends on the generation of DG, a substrate from the action of ATGL. Finally, MGL acts to liberate glycerol and the final FFA.

3. Regulation of Lipolysis via the Coordinated Action of Lipases and Cofactors

The discovery of perilipin 1 provided proof of cofactors which exist in the cytoplasm and on the lipid droplet surface [34]. Perilipin 1 is the founding member of the perilipin, adipophilin, and TIP47 family (referred to as the PAT/perilipin family protein) of lipid droplet-coated proteins [35] and is expressed mostly in white adipose tissue, where it coats lipid droplets, and in steroidogenic tissue [36]. Perilipin 1 has as many as six phosphorylation sites (Ser81, Ser222, Ser276, Ser433, Ser492, and Ser517) in adipocytes by PKA [3740]. Several studies have reported that perilipin 1 is multifunctional and is capable of reducing basal lipolysis via combining HSL with lipid droplets to form a barrier [41] and promotes the lipolysis movement of perilipin 1 away from fat droplets [42] through lipase-dependent and -independent mechanisms [43]. Moreover, the CGI-58, also known as α/β hydrolase domain-containing protein 5 (ABHD5), was found to increase the TG hydrolase activity of ATGL owing to a direct interaction with ATGL proteins [44]. CGI-58 also has the ability to be associated with perilipin 1 [35, 4547], demonstrating that the localizations of both perilipin 1 and CGI-58 are centrally involved in the organization and regulation of lipolytic effector interactions in both basal and hormone-stimulated states. The conceptual consensus schema is described below (Figure 3). Under basal conditions, CGI-58 localizes on the lipid droplet surfaces with perilipin 1, although ATGL exists predominantly within the cytoplasm [48], resulting in an attenuation of the interaction of ATGL with CGI-58 [49]. HSL is also located entirely in the cytoplasm, where it is nonphosphorylated and removed from lipid droplets, thereby reducing the hydrolysis activity of TG in adipocytes [36]. In contrast, hormonal activation of β-ARs-PKA provokes the association of CGI-58 with ATGL in fragmented lipid droplets following the rapid, within minutes, dissociation of PKA-phosphorylated perilipin 1 at Ser517 and CGI-58 [38, 48]. During that time, PKA promotes both phosphorylation and translocation of phosphorylated HSL at Ser659 and Ser660 from the cytoplasm to lipid droplets [50], and, in turn, perilipin 1 acts as a scaffold protein to bind HSL with lipid droplets [34], which results in an inducement of the maximal lipolytic response. Thus, serial modification events of lipolytic molecules, which support the localization of lipases, would play a critical role in the adaptive alteration of the lipolytic response in white adipocytes by physical exercise.

Figure 3: Under basal and inactivated conditions, perilipin 1 and CGI-58 form a complex on the surface of lipid droplets (a). On the other hand, PKA activation leads to the phosphorylation of both HSL and perilipin 1, resulting in HSL and perilipin 1 forming a complex on the surface of lipid droplets. Released CGI-58 from phosphorylated perilipin 1 binds to ATGL to induce lipolysis (b).

4. Effect of ET on the Number of β-ARs, Which Is the First Step in the Mobilization of the Lipolytic Cascade

As mentioned in the above sections, stimulation of the β-ARs-AC system in white adipocytes results in a change in intracellular cAMP production and in the subsequent activation of PKA. Thus, an increase in the number of the β-ARs, which are expressed on the cell surfaces, would be expected to play a key role in the upregulation of lipolysis that is caused by ET. In ET, however, there is a small amount of evidence that indicates no change in the number of β-ARs [51, 52], which are measured by hydrophobic ligands, compared to the primary adipocytes of sedentary control rats. Moreover, investigation using hydrophilic ligands has demonstrated that the level of β-ARs on cell surfaces is significantly decreased due to ET in rat [53], indicating that the level of β-ARs by ET, at least in part, might be internalized into the cytoplasm rather than being increased on the cell surfaces. In addition, in rat, it has been shown that enhancement of β-ARs-AC coupling is observed in white adipocytes from ET [54, 55]. These results indicate that an ET-induced increase in lipolysis is not dependent on the number of β-ARs but rather the enhancement of the association efficiency of both β-ARs and Gs proteins. Thus, an ET-induced enhancement of lipolysis might be mediated by an adaptive alteration in post β-ARs.

Under ET, repeat exposure of high levels of plasma catecholamines during bouts of daily exercise might be likely to trigger downregulation and change the localization of β-ARs into the cytoplasm in white adipocytes. Some very elegant studies conducted by Shenoy and coworkers [56] have shown that -ARs have a functional turnover cycle from the cellular surface to the cytosol via ubiquitination in a catecholamine dose-dependent manner. Of note, the adaptive change of adipocytes in response to ET appears to be the result of the integrative effect of bouts of acute exercise. Therefore, an understanding of the acute exercise-induced trafficking events of -AR would support the clarification of adaptive moderation of β-ARs by ET. In rat primary epididymal adipocytes, our results obtained from acute exercise demonstrated that localization of -ARs on the cell surface was upregulated at least 3 hours after exercise with reduced interaction of β-arrestin 2 and -AR, whereas it returned to the sedentary control levels 24 hours after exercise [57] (Figure 4). Loss of the combination of β-arrestin 2 and -AR resulted in a reduction in -AR ubiquitination, which thereby attenuated the internalization of -ARs into the cytoplasm. However, internalized -ARs were capable of quick recycling on the cell surface [58]. Together, the turnover of -ARs that was induced by every single bout of exercise might have been the result of the reduced levels of -ARs on the cell surfaces by ET, because, in this instance, there were no changes in the total amount of β-AR [5153] (Figure 4).

Figure 4: Internalization of -ARs from plasma membrane to intracellular space is modified by acute exercise in white adipocytes. HE-induced increase in the localizations of β-ARs into the cytoplasm might be a result of, at least in part, a mobilization of the trafficking of -ARs, which is caused by daily repeated bouts of acute exercise.

5. Adaptive Alteration in G-Proteins by Habitual Physical Exercise

It is known that both Gs protein α subunit (Gsα) and Gi protein α subunit (Giα), which are dissociated from β- and γ-subunits by stimulation of α- and β-ARs, play key roles in the synergistic action of AC in white adipocytes. ET reportedly provoked a significant increase in AC activity of rat white adipocytes [59], accompanied by a decrease in the levels of Giα protein, but caused no change in the levels of Gsα proteins in rat white adipocytes [60]. Moreover, ET significantly decreased the levels of Giα2 protein, which predominantly inhibits AC activity, in rat white adipocytes [61] and in rat pancreatic islets [62]. These results indicate that ET positively regulates the signal transduction systems through the inhibition of Giα function in adipose cells, which leads to the activation of AC. However, the mechanism(s) by which ET induces the downregulation of Giα2 protein is unknown. In our previous study, acute exercise transiently downregulated the levels of Giα2 proteins at least 3 hours after exercise via ubiquitin-proteasomal degradation machinery in rat white adipocytes [63] (Figure 5), suggesting the possibility that the downregulation of Giα2 protein by ET might also be associated with acute exercise-induced proteolysis action, because ET is often defined by a repeat of bouts of acute exercise. Indeed, it is known that promotion of the ubiquitin-proteasome system is dependent on intracellular ATP, which is produced in several cells during exercise [9]. Moreover, the levels of MuRF-1, a muscle-specific E3 ligase, are reportedly reduced by ET in chronic heart failure patients [64]. Thus, in ET, the conspicuous effect of exercise on cellular energy production and selective transcriptional systems might be one of the triggers for the downregulation of Giα2 proteins in white adipocytes (Figure 5). Such a conclusion, however, requires further study.

Figure 5: In white adipocytes, acute exercise accelerates the degradation of Gαi2 proteins through the ubiquitin-proteasome system during, and at least 3 hours after, exercise. This mechanism might become a trigger for habitual decreases in the levels of Gαi2 by ET.

6. Manipulation of Lipolytic Molecules by Physical Exercise to Supply Energy

An understanding of the regulatory mechanisms underlying basal and hormone-stimulated lipolysis in adipocytes has evolved in recent years. However, little is known about the effect of ET on the molecular behavior of lipolytic proteins, that is, perilipin 1 and CGI-58, in white adipocytes. In rat, ET studies have shown no change in intracellular cAMP accumulation in white adipocytes compared with a sedentary control [51], suggesting the possibility that the molecular behavior of lipolytic proteins, which occur in the cell, plays a key role in the HE-induced enhancement of the lipolytic response. Indeed, our previous study indicated that white adipocytes obtained from ET rat enhance the levels of catalytic subunits of PKA proteins and PKA-anchoring protein 150 (AKAP150), which promotes the binding of PKA and its substrate, with activation of both PKA and HSL in the lipid droplet fraction of adipocyte homogenate [65]. These results would explain the phenomena whereby the ET-induced anchoring of AKAP150 to PKA enhances the magnitude of cAMP signaling in white adipocytes, even if accumulations of intracellular cAMP fail to increase as a result of ET. In rat, levels of HSL in adipocytes reportedly are upregulated by ET despite obesity [12] or normal circumstances in an individual [66], suggesting that the AKAP150-mediated enhancing action of PKA easily provokes the interaction of PKA with HSL, thereby activating the phosphorylation of HSL in cytoplasmic space. However, in rat white adipocytes, the phosphorylation of HSL by acute exercise is accompanied by an increase in intracellular cAMP production [63]. Thus, the functional alteration in AKAP150 might play a critical role in the adaptive augmentation of lipolytic responses by ET in white adipocytes.

Alsted and colleagues were the first to report that levels of ATGL protein are significantly increased in human skeletal muscle by ET [67], although adipose tissue is used to identify ATGL [13]. It is noteworthy that the deletion of ATGL in mice impairs exercise performance [68] and that ATGL knockout mice show no increase in circulating FFA levels during exercise [69], suggesting that a molecular change in ATGL, as well as HSL, plays a role in supplying FFA from white adipocytes during physical exercise as a fuel for metabolism. To date, however, little is known about the effect of ET on the molecular changes of ATGL in white adipocytes. Recently, in rat, we demonstrated that mRNA, protein levels of ATGL, and HSL proteins all are upregulated by ET and that DNA-binding activities of peroxisome proliferation-activated receptor-γ 2 (PPAR-γ2) are closely associated with the ET-induced upregulation of ATGL [70]. Under these conditions, the binding of CGI-58 to ATGL was significantly increased on the lipid droplets with dissociations of CGI-58 and perilipin 1. These results indicate that the ET-induced acceleration of lipolytic responses is, at least in part, mediated by the hyperfunction of newly synthesized protein via the transcriptional activation of ATGL. Meanwhile, there is no evidence as to whether PKA-mediated phosphorylation of ATGL is involved in the hydrolysis of TG by ET, although at least one previous study has demonstrated that the increased phosphorylation of ATGL at Ser406, a PKA-mediated phosphorylation site, during both fasting and moderate single bouts of exercise is associated with an elevated rate of lipolysis in mice [71]. In our pilot study, ET showed higher levels of phosphorylated ATGL compared with the sedentary control in rat epididymal white adipocytes (unpublished data). These results suggest the possibility that ET might cause a phosphorylation-provoked conformational change in the protein structures of ATGL, which might result in a hypercombination of CGI-58 on lipid droplets [70], thereby enhancing the lipolytic responses in rat white adipocytes. In conclusion, several results have indicated that localization and/or phosphorylation of lipolytic molecules, such as perilipin 1, CGI-58, HSL, and ATGL, has a central function in the ET-induced adaptive alteration of lipolysis in white adipocytes and that the AKAP150-mediated activation of PKA also plays a key role in this mechanism (Figure 6).

Figure 6: Summary of HE-induced adaptive changes of lipolytic molecules in white adipocytes. ET constantly promotes the expression levels of ATGL and HSL proteins. These conditions are likely to give rise to the stimulation of lipolytic responses through adaptive changes in molecules, such as increases in the anchoring action of AKAP150, higher levels of phosphorylated HSL, and augmentation of the formation of a complex of both HSL/perilipin 1 and ATGL/CGI-58 on the surface of lipid droplet. ↑: upregulation of function and expression levels of each molecule.

7. Conclusion

It is well documented that exercise of moderate intensity accelerates the lipolytic responses in human white adipocytes [7274]. In this review, studies showing both ET and acute exercise of light to moderate intensity [5052, 56, 5863, 65, 66, 70] indicated that moderate intensity of ET clearly provokes an enhancement of lipolysis in white adipocytes with an orchestral alteration in lipolytic molecules in a positive manner. However, little is known about the high-intensity exercise-induced behavior of lipolytic molecules in white adipocytes so far. Further studies are required to clarify this point.

A clarification of HE-induced molecular changes in a lipolytic cascade would apply not only to the prevention of obesity but also to the elucidation of a methodology for advances in exercise effectiveness. However, in white adipocytes no complete evidence exists to explain the mechanism(s) underlying the HE-induced adaptive changes in lipolysis. In particular, there are no new insights into the alterations in G protein-coupled receptors, nor into the family of G-proteins and related modification events brought about by HE, although a few results obtained in our studies have shown that ubiquitin-proteasome system plays a role in acute exercise-mediated amplification of the lipolytic cascade via the expression levels of both -AR and Giα2 proteins. However, it is noteworthy that more than 200 genes that regulate lipid droplet morphology have been identified in Drosophila [75], suggesting that new molecules, which are unknown in mammalian species, would be related to the regulation of lipolytic events in white adipocytes with or without exercise. In the near future, the search for new molecules with the aim of elucidating their functions in an exercise-specific manner will shed new light on the calculations of a highly effective lipolytic system of exercise and will enhance the biological understanding of white adipocytes as a “vehicle” for the storage and supply of energy.

Abbreviations

ET:Continuous exercise training
GPCRs:G-protein coupled receptors
-AR:Adrenergic receptor
-R:Receptor
Gsα:Gs protein α subunit
Giα:Gi protein α subunit
AC:Adenylyl cyclase
P:Phosphorylation
PKA:cAMP-dependent protein kinase A
TG:Triacylglycerol
DG:Diacylglycerol
MG:Monoacylglycerol
IRS-1:Insulin receptor substrate-1
PI3-K:Phosphatidylinositol 3-kinase
PKB:Protein kinase B
PDE-3B:Phosphodiesterase-3B
HSL:Hormone-sensitive lipase
ATGL:Adipose triglyceride lipase
MGL:Monoacylglycerol lipase
AMPK:AMP activated protein kinase
CGI-58:Comparative gene identification-58
PAT/perilipin family proteins:Perilipin/perilipin 1, adipophilin/perilipin 2, TIP47/perilipin 3, S3-12/perilipin 4, and muscle lipid droplet protein/perilipin 5 family proteins
AKAP150:PKA-anchoring protein 150
PPAR-γ2:Peroxisome proliferation-activated receptor-γ 2.

Conflict of Interests

The authors have declared that there is no conflict of interests.

Acknowledgment

This work was supported in part by Grant-in-Aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science and Technology.

References

  1. B. M. Popkin and M. M. Slining, “New dynamics in global obesity facing low- and middle-income countries,” Obesity Reviews, vol. 14, supplement 2, pp. 11–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Borén, M.-R. Taskinen, S.-O. Olofsson, and M. Levin, “Ectopic lipid storage and insulin resistance: a harmful relationship,” Journal of Internal Medicine, vol. 274, no. 1, pp. 25–40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Perseghin, “Muscle lipid metabolism in the metabolic syndrome,” Current Opinion in Lipidology, vol. 16, no. 4, pp. 416–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Vermathen, P. Saillen, A. Boss, M. Zehnder, and C. Boesch, “Skeletal muscle 1H MRSI before and after prolonged exercise. I. muscle specific depletion of intramyocellular lipids,” Magnetic Resonance in Medicine, vol. 68, no. 5, pp. 1357–1367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Louche, P.-M. Badin, E. Montastier et al., “Endurance exercise training up-regulates lipolytic proteins and reduces triglyceride content in skeletal muscle of obese subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 12, pp. 4863–4871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G.-J. van der Heijden, Z. J. Wang, Z. D. Chu et al., “A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, hispanic adolescents,” Obesity, vol. 18, no. 2, pp. 384–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Mauriege, J. Galitzky, M. Berlan, and M. Lafontan, “Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences,” European Journal of Clinical Investigation, vol. 17, no. 2, pp. 156–165, 1987. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lafontan and M. Berlan, “Fat cell adrenergic receptors and the control of white and brown fat cell function,” Journal of Lipid Research, vol. 34, no. 7, pp. 1057–1091, 1993. View at Google Scholar · View at Scopus
  9. P. Arner, E. Kriegholm, P. Engfeldt, and J. Bolinder, “Adrenergic regulation of lipolysis in situ at rest and during exercise,” The Journal of Clinical Investigation, vol. 85, no. 3, pp. 893–898, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Castan, P. Valet, N. Quideau et al., “Antilipolytic effects of α2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes,” The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 266, no. 4, pp. R1141–R1147, 1994. View at Google Scholar · View at Scopus
  11. J. E. Campbell, S. Fediuc, T. J. Hawke, and M. C. Riddell, “Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis,” Metabolism: Clinical and Experimental, vol. 58, no. 5, pp. 651–660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Hashimoto, K. Sato, and M. Iemitsu, “Exercise-inducible factors to activate lipolysis in adipocytes,” Journal of Applied Physiology, vol. 115, no. 2, pp. 260–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Zimmermann, J. G. Strauss, G. Haemmerle et al., “Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase,” Science, vol. 306, no. 5700, pp. 1383–1386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. E. Bickel, J. T. Tansey, and M. A. Welte, “PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores,” Biochimica et Biophysica Acta, vol. 1791, no. 6, pp. 419–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Yamaguchi, “Crucial role of CGI-58/alpha/beta hydrolase domain-containing protein 5 in lipid metabolism,” Biological & Pharmaceutical Bulletin, vol. 33, no. 3, pp. 342–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-J. Syu and A. R. Saltiel, “Lipotransin: a novel docking protein for hormone-sensitive lipase,” Molecular Cell, vol. 4, no. 1, pp. 109–115, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Langin and P. Arner, “Importance of TNFα and neutral lipases in human adipose tissue lipolysis,” Trends in Endocrinology and Metabolism, vol. 17, no. 8, pp. 314–320, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Duncan, M. Ahmadian, K. Jaworski, E. Sarkadi-Nagy, and H. S. Sul, “Regulation of lipolysis in adipocytes,” Annual Review of Nutrition, vol. 27, pp. 79–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Gómez-Ambrosi, G. Frühbeck, M. Aguado, F. I. Milagro, J. Margareto, and A. J. Martínez, “Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats,” International Journal of Molecular Medicine, vol. 8, no. 1, pp. 103–109, 2001. View at Google Scholar · View at Scopus
  20. B. B. Fredholm, “Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactivation on lipolysis in rat fat cells,” Acta Physiologica Scandinavica, vol. 102, no. 2, pp. 191–198, 1978. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Robertson and S. A. Little, “Down-regulation of prostaglandin E receptors and homologous desensitization of isolated adipocytes,” Endocrinology, vol. 113, no. 5, pp. 1732–1738, 1983. View at Google Scholar
  22. R. C. Honnor, G. S. Dhillon, and C. Londos, “cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior,” The Journal of Biological Chemistry, vol. 260, no. 28, pp. 15122–15129, 1985. View at Google Scholar · View at Scopus
  23. R. C. Honnor, G. S. Dhillon, and C. Londos, “cAMP-dependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators,” The Journal of Biological Chemistry, vol. 260, no. 28, pp. 15130–15138, 1985. View at Google Scholar · View at Scopus
  24. A. S. Greenberg, W.-J. Shen, K. Muliro et al., “Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway,” The Journal of Biological Chemistry, vol. 276, no. 48, pp. 45456–45461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Holm, “Molecular mechanisms regulating hormone-sensitive lipase and lipolysis,” Biochemical Society Transactions, vol. 31, part 6, pp. 1120–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Egan, A. S. Greenberg, M.-K. Chang, S. A. Wek, M. C. Moos Jr., and C. Londos, “Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 18, pp. 8537–8541, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Enoksson, E. Degerman, E. Hagström-Toft, V. Large, and P. Arner, “Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man,” Diabetologia, vol. 41, no. 5, pp. 560–568, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Strålfors and R. C. Honnor, “Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity,” European Journal of Biochemistry, vol. 182, no. 2, pp. 379–385, 1989. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. Watt, A. G. Holmes, S. K. Pinnamaneni et al., “Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 3, pp. E500–E508, 2006. View at Google Scholar
  30. J. A. Villena, S. Roy, E. Sarkadi-Nagy, K.-H. Kim, and S. S. Hei, “Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis,” The Journal of Biological Chemistry, vol. 279, no. 45, pp. 47066–47075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Jenkins, D. J. Mancuso, W. Yan, H. F. Sims, B. Gibson, and R. W. Gross, “Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities,” The Journal of Biological Chemistry, vol. 279, no. 47, pp. 48968–48975, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Smirnova, E. B. Goldberg, K. S. Makarova, L. Lin, W. J. Brown, and C. L. Jackson, “ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells,” The EMBO Reports, vol. 7, no. 1, pp. 106–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Bartz, J. K. Zehmer, M. Zhu et al., “Dynamic activity of lipid droplets: protein phosphorylation and GTP-mediated protein translocation,” Journal of Proteome Research, vol. 6, no. 8, pp. 3256–3265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. D. L. Brasaemle, “The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis,” The Journal of Lipid Research, vol. 48, no. 12, pp. 2547–2559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. L. Brasaemle and N. E. Wolins, “Packaging of fat: an evolving model of lipid droplet assembly and expansion,” The Journal of Biological Chemistry, vol. 287, no. 4, pp. 2273–2279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Greenberg, J. J. Egan, S. A. Wek, N. B. Garty, E. J. Blanchette-Mackie, and C. Londos, “Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets,” The Journal of Biological Chemistry, vol. 266, no. 17, pp. 11341–11346, 1991. View at Google Scholar · View at Scopus
  37. H. Miyoshi, J. W. Perfield II, S. C. Souza et al., “Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase a-stimulated lipolysis in adipocytes,” The Journal of Biological Chemistry, vol. 282, no. 2, pp. 996–1002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Miyoshi, S. C. Souza, H.-H. Zhang et al., “Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms,” The Journal of Biological Chemistry, vol. 281, no. 23, pp. 15837–15844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Sztalryd, G. Xu, H. Dorward et al., “Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation,” The Journal of Cell Biology, vol. 161, no. 6, pp. 1093–1103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. T. Tansey, A. M. Huml, R. Vogt et al., “Functional studies on native and mutated forms of perilipins: a role in protein kinase a-mediated lipolysis of triacylglycerols in Chinese hamster ovary cells,” The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8401–8406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J. T. Tansey, C. Sztalryd, J. Gruia-Gray et al., “Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6494–6499, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. G. M. Clifford, F. B. Kraemer, S. J. Yeaman, and R. G. Vernon, “Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation during the lactation cycle of the rat,” Metabolism: Clinical and Experimental, vol. 50, no. 11, pp. 1264–1269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. D. L. Brasaemle, V. Subramanian, A. Garcia, A. Marcinkiewicz, and A. Rothenberg, “Perilipin A and the control of triacylglycerol metabolism,” Molecular and Cellular Biochemistry, vol. 326, no. 1-2, pp. 15–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Lass, R. Zimmermann, G. Haemmerle et al., “Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome,” Cell Metabolism, vol. 3, no. 5, pp. 309–319, 2006. View at Publisher · View at Google Scholar
  45. V. Subramanian, A. Rotlienberg, C. Gomez et al., “Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes,” The Journal of Biological Chemistry, vol. 279, no. 40, pp. 42062–42071, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Yamaguchi, N. Omatsu, S. Matsushita, and T. Osumi, “CGI-58 interacts with perilipin and is localized to lipid droplets: possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome,” The Journal of Biological Chemistry, vol. 279, no. 29, pp. 30490–30497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. G. Granneman, H.-P. H. Moore, R. Krishnamoorthy, and M. Rathod, “Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl),” The Journal of Biological Chemistry, vol. 284, no. 50, pp. 34538–34544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. G. Granneman, H.-P. H. Moore, R. L. Granneman, A. S. Greenberg, M. S. Obin, and Z. Zhu, “Analysis of lipolytic protein trafficking and interactions in adipocytes,” The Journal of Biological Chemistry, vol. 282, no. 8, pp. 5726–5735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Yamaguchi, N. Omatsu, E. Morimoto et al., “CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation,” Journal of Lipid Research, vol. 48, no. 5, pp. 1078–1089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. C.-L. Su, C. Sztalryd, J. A. Contreras, C. Holm, A. R. Kimmel, and C. Londos, “Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes,” The Journal of Biological Chemistry, vol. 278, no. 44, pp. 43615–43619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Bukowiecki, J. Lupien, N. Follea, A. Paradis, D. Richard, and J. LeBlanc, “Mechanism of enhanced lipolysis in adipose tissue of exercise-trained rats.,” The American Journal of Physiology, vol. 239, no. 6, pp. E422–E429, 1980. View at Google Scholar · View at Scopus
  52. R. E. Shepherd and M. D. Bah, “Cyclic AMP regulation of fuel metabolism during exercise: regulation of adipose tissue lipolysis during exercise,” Medicine and Science in Sports and Exercise, vol. 20, no. 6, pp. 531–538, 1988. View at Google Scholar · View at Scopus
  53. K. Suda, T. Izawa, T. Komabayashi, M. Tsuboi, and S. Era, “Effect of insulin on adipocyte lipolysis in exercise-trained rats,” Journal of Applied Physiology, vol. 74, no. 6, pp. 2935–2939, 1993. View at Google Scholar · View at Scopus
  54. R. S. Williams and T. Bishop, “Enhanced receptor-cyclase coupling and augmented catecholamine-stimulated lipolysis in exercising rats,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 243, no. 5, pp. E345–E351, 1982. View at Google Scholar · View at Scopus
  55. T. Izawa, T. Komabayashi, M. Tsuboi, E. Koshimizu, and K. Suda, “Augmentation of catecholamine-stimulated [3H]GDP release in adipocyte membranes from exercise-trained rats,” The Japanese Journal of Physiology, vol. 36, no. 5, pp. 1039–1045, 1986. View at Publisher · View at Google Scholar · View at Scopus
  56. S. K. Shenoy, P. H. McDonald, T. A. Kohout, and R. J. Lefkowitz, “Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin,” Science, vol. 294, no. 5545, pp. 1307–1313, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Ogasawara, M. Sanpei, N. Rahman et al., “β-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, β-arrestin-2, and the ubiquitin-proteasome pathway,” The FASEB Journal, vol. 20, no. 2, pp. 350–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Macia, M. Partisani, O. Paleotti, F. Luton, and M. Franco, “Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor,” Journal of Cell Science, vol. 125, no. 17, pp. 4026–4035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Izawa, T. Komabayashi, T. Mochizuki, K. Suda, and M. Tsuboi, “Enhanced coupling of adenylate cyclase to lipolysis in permeabilized adipocytes from trained rats,” Journal of Applied Physiology, vol. 71, no. 1, pp. 23–29, 1991. View at Google Scholar · View at Scopus
  60. T. Izawa, T. Komabayashi, S. Shinoda, K. Suda, M. Tsuboi, and E. Koshimizu, “Possible mechanism of regulating adenylate cyclase activity in adipocyte membranes from exercise-trained male rats,” Biochemical and Biophysical Research Communications, vol. 151, no. 3, pp. 1262–1298, 1988. View at Publisher · View at Google Scholar · View at Scopus
  61. J. L. Nieto, I. D. Laviada, A. Guillén, and A. Haro, “Adenylyl cyclase system is affected differently by endurance physical training in heart and adipose tissue,” Biochemical Pharmacology, vol. 51, no. 10, pp. 1321–1329, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Urano, T. Sakurai, H. Ueda, J. Ogasawara, M. Takei, and T. Izawa, “Desensitization of the inhibitory effect of norepinephrine on insulin secretion from pancreatic islets of exercise-trained rats,” Metabolism: Clinical and Experimental, vol. 53, no. 11, pp. 1424–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Ogasawara, T. Sakurai, N. Rahman et al., “Acute exercise alters Gαi2 protein expressions through the ubiquitin-proteasome proteolysis pathway in rat adipocytes,” Biochemical and Biophysical Research Communications, vol. 323, no. 3, pp. 1109–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Ciechanover, “Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1824, no. 1, pp. 3–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Gielen, M. Sandri, I. Kozarez et al., “Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized leipzig exercise intervention in chronic heart failure and aging catabolism study,” Circulation, vol. 125, no. 22, pp. 2716–2727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Nomura, H. Kawanami, H. Ueda, T. Kizaki, H. Ohno, and T. Izawa, “Possible mechanisms by which adipocyte lipolysis is enhanced in exercise-trained rats,” Biochemical and Biophysical Research Communications, vol. 295, no. 2, pp. 236–242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. T. J. Alsted, L. Nybo, M. Schweiger et al., “Adipose triglyceride lipase in human skeletal muscle is upregulated by exercise training,” American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 3, pp. E445–E453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Huijsman, C. van de Par, C. Economou et al., “Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 2, pp. E505–E513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Schoiswohl, M. Schweiger, R. Schreiber et al., “Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids,” Journal of Lipid Research, vol. 51, no. 3, pp. 490–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Ogasawara, T. Sakurai, T. Kizaki et al., “Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes,” PLoS ONE, vol. 7, no. 7, Article ID e40876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Pagnon, M. Matzaris, R. Stark et al., “Identification and functional characterization of protein kinase A phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase,” Endocrinology, vol. 153, no. 9, pp. 4278–4289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. P. E. Hall, S. R. Smith, D. B. Jack, and M. J. Kendall, “The influence of beta-adrenoceptor blockade on the lipolytic response to exercise,” Journal of Clinical Pharmacy and Therapeutics, vol. 12, no. 2, pp. 101–106, 1987. View at Publisher · View at Google Scholar · View at Scopus
  73. R. R. Wolfe, S. Klein, F. Carraro, and J.-M. Weber, “Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 258, no. 2, part 1, pp. E382–E389, 1990. View at Google Scholar · View at Scopus
  74. S. Klein, E. F. Coyle, and R. R. Wolfe, “Fat metabolism during low-intensity exercise in endurance-trained and untrained men,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 267, no. 6, pp. E934–E940, 1994. View at Google Scholar · View at Scopus
  75. Y. Guo, T. C. Walther, M. Rao et al., “Functional genomic screen reveals genes involved in lipid-droplet formation and utilization,” Nature, vol. 453, no. 7195, pp. 657–661, 2008. View at Publisher · View at Google Scholar · View at Scopus